Patents by Inventor Simon L. Stubbs

Simon L. Stubbs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9260711
    Abstract: The present invention to relates to methods and kits which can be used to amplify nucleic acids with the advantage of decreasing user time and possible contamination. The PCR reagents are bound to a solid matrix for easy processing and amplification of DNA samples.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: February 16, 2016
    Assignee: GE HEALTHCARE UK LIMITED
    Inventors: Kathryn L. Lamerton, Cheryl L. Potts, Simon L. Stubbs, Michael K. Kenrick
  • Publication number: 20140154667
    Abstract: The present invention to relates to methods and kits which can be used to amplify nucleic acids with the advantage of decreasing user time and possible contamination. The PCR reagents are bound to a solid matrix for easy processing and amplification of DNA samples.
    Type: Application
    Filed: March 13, 2013
    Publication date: June 5, 2014
    Applicant: GE HEALTHCARE UK LIMITED
    Inventors: KATHRYN L. LAMERTON, CHERYL L. POTTS, SIMON L. STUBBS, MICHAEL K. KENRICK
  • Patent number: 8076148
    Abstract: The present invention relates to a cytochrome c-reporter fusion protein construct comprising a modified cytochrome c protein which targets the mitochondria and has a reduced ability to induce apoptosis in a living cell. The invention also relates to nucleic acid constructs encoding such protein fusions and cells stably transfected with such constructs. The stably transfected cells of the invention can be used in assays to detect apoptosis.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: December 13, 2011
    Assignee: GE Healthcare UK Limited
    Inventors: Simon L. Stubbs, Michael J. Francis, Adrian Cushing, Rahman A. Ismail
  • Publication number: 20090053748
    Abstract: The present invention relates to a a cytochrome c-reporter fusion protein construct comprising a modified cytochrome c protein which targets the mitochondria and has a reduced ability to induce apoptosis in a living cell. The invention also relates to nucleic acid constructs encoding such protein fusions and cells stably transfected with such constructs. The stably transfected cells of the invention can be used in assays to detect apoptosis.
    Type: Application
    Filed: December 17, 2004
    Publication date: February 26, 2009
    Inventors: Simon L. Stubbs, Michael J. Francis, Adrian Cushing, Rahman A. Ismail